3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Lymphoma
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thyroid Nodule
1
Small Cell Lung Carcinoma
1
Precancerous Conditions
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Cervical Intraepithelial Neoplasia Grade 2/3
1
Carcinoma, Non-Small-Cell Lung
1
Biopsy, Fine-Needle
1
Anus Neoplasms
1
Interventions
Cisplatin
178
Paclitaxel
79
Radiotherapy
76
Carboplatin
70
Brachytherapy
69
pembrolizumab
63
Bevacizumab
40
Gemcitabine
28
Radiation
27
Topotecan
26
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
25
Nivolumab
22
Colposcopy
22
human papillomavirus vaccine, L1 type 16, 18
21
Magnetic Resonance Spectroscopy
21
Drug Therapy
20
atezolizumab
19
Platinum
19
Papillomavirus Vaccines
18
Radiotherapy, Intensity-Modulated
17
Docetaxel
17
Taxes
16
Cyclophosphamide
16
Biopsy
16
Early Intervention, Educational
15
1,2-diaminocyclohexaneplatinum II citrate
15
Methods
14
Blood Specimen Collection
14
fludarabine
13
Injections
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Uterine Cervical Neoplasms
×
Cytological Techniques
×
Clear all
NCT02067468
2019-09-19
ASCUS-COL
Universidad de Antioquia
Phase NA
Completed
2,661 enrolled
18 charts